Burden of female‐specific cancers in China from 1990 to 2021: A systematic analysis for the Global Burden of Disease Study 2021

Breast cancer and reproductive system cancers remain significant public health threats for Chinese women. The year‐ and age‐specific estimates of the incidence, mortality, and disability‐adjusted life‐years (DALYs) associated with breast, cervical, ovarian, and uterine cancers in China from 1990 to 2021 were generated from the Global Burden of Disease, Injuries, and Risk Factors 2021 study. In 2021, China reported 385.84 thousand incident cases of female breast cancer, followed by cervical cancer (132.79 thousand), uterine cancer (72.02 thousand), and ovarian cancer (41.24 thousand). Breast cancer ranked as the primary cause of cancer‐related deaths, followed by cervical cancer. Breast, ovarian, and uterine cancer cases are projected to rise by 2050, which will exceed those recorded in 2021.Various inequities have been identified across four types of cancers affecting women, which underscores the need for tailored national cancer control strategies. Projections indicate that by 2050, the incidence of breast, ovarian, and uterine cancers will surpass 2021 levels, which underscores the necessity for targeted prevention, early detection, and treatment strategies. Emphasis should be placed on primary prevention and screening for breast and cervical cancers, whereas efforts for uterine and ovarian cancers should focus on implementing early diagnosis and treatment measures.